Center for Biologics Evaluation & Research
Associate Director for Policy Rebecca Devine, PhD, leaves to pursue other interests. She has served in the post since 1994. Special Assistant to the Associate Director for Policy Robert Yetter will fill the position on detail until a replacement can be found. Jesse Goodman is also on detail from the commissioner's office as deputy director for medicine, the position held by David Feigal, MD, before he left to head the Center for Devices & Radiological Health. Former FDA Baltimore District Office Director Elaine Cole has become director of CBER's Division of Inspection and Surveillance. Jim Cohen has joined CBER's Office of Compliance and Biologics as deputy director for operations. He was previously FDA associate chief counsel
Learn what's happening at the US FDA. On the go.
More from Archive
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
More from Pink Sheet
Revised recommendation is based on most recent data on circulating strains in US, where KP.3 is now dominant. Novavax sticks with plans targeting the JN.1 ‘parent strain.’
Pink Sheet reporter and editors discuss the US FDA’s changes to the COVID-19 vaccine indication and its revocation of the vaccine emergency use authorizations, as well as new vaccine coverage and reimbursement questions.
To make your document look professionally produced, Word provides header, footer, cover page, and text box designs that complement each other. For example, you can add a matching cover page, header, and sidebar. Click Insert and then choose the elements you want from the different galleries.